• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对破伤风加强免疫缺乏早期抗毒素反应。

Lack of early antitoxin response to tetanus booster.

作者信息

Porter J D, Perkin M A, Corbel M J, Farrington C P, Watkins J T, Begg N T

机构信息

Public Health Laboratory Service, Communicable Disease Surveillance Centre, London, UK.

出版信息

Vaccine. 1992;10(5):334-6. doi: 10.1016/0264-410x(92)90373-r.

DOI:10.1016/0264-410x(92)90373-r
PMID:1574917
Abstract

Tetanus immune globulin (TIG) continues to be recommended in persons with tetanus-prone wounds who have incomplete or unknown tetanus immunization status. The aim of this study was to determine whether, following a booster dose of tetanus toxoid in adults who had not been immunized in the previous 10 years, there was an antitoxin response to tetanus toxoid booster within 4 days. Thirty-one adults were investigated, baseline levels for tetanus antitoxin assayed using an ELISA technique, and an injection of adsorbed tetanus toxoid (0.5 ml) given. Blood samples for tetanus antitoxin levels were taken at daily intervals for the 4 days following immunization. Tetanus boosters following the primary course but before the present study did not significantly increase the levels of pre-study tetanus antitoxin and following the study booster there was no difference between the preboost levels and the levels on days 1 to 4. This finding indicates that the present recommendations for the use of TIG in tetanus-prone wounds are appropriate.

摘要

对于破伤风易感性伤口且破伤风免疫状态不完全或不明的人群,仍建议使用破伤风免疫球蛋白(TIG)。本研究的目的是确定在过去10年未接种疫苗的成年人中,给予一剂破伤风类毒素加强针后,4天内是否会出现针对破伤风类毒素加强针的抗毒素反应。研究了31名成年人,采用ELISA技术检测破伤风抗毒素的基线水平,并注射吸附破伤风类毒素(0.5毫升)。免疫接种后的4天内每天采集血样检测破伤风抗毒素水平。初次免疫过程后但在本研究之前的破伤风加强针并未显著提高研究前破伤风抗毒素水平,且在研究加强针后,加强前水平与第1至4天的水平之间没有差异。这一发现表明,目前关于在破伤风易感性伤口中使用TIG的建议是合适的。

相似文献

1
Lack of early antitoxin response to tetanus booster.对破伤风加强免疫缺乏早期抗毒素反应。
Vaccine. 1992;10(5):334-6. doi: 10.1016/0264-410x(92)90373-r.
2
Decline of tetanus antitoxin level with age in taiwan.台湾地区破伤风抗毒素水平随年龄的下降情况。
J Formos Med Assoc. 2009 May;108(5):395-401. doi: 10.1016/S0929-6646(09)60083-8.
3
Antibody response to successive booster doses of tetanus toxoid in adults.成人对破伤风类毒素连续加强剂量的抗体反应。
Infect Immun. 1974 Jul;10(1):1-5. doi: 10.1128/iai.10.1.1-5.1974.
4
[Preventive tetanus immunization and avoidance of side effects of booster immunization].预防性破伤风免疫与避免加强免疫的副作用
Dtsch Med Wochenschr. 1992 Dec 11;117(50):1903-6. doi: 10.1055/s-2008-1062527.
5
Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.日本旅行者破伤风类毒素抗体的血清流行率和加强免疫接种效果。
J Infect Chemother. 2014 Jan;20(1):35-7. doi: 10.1016/j.jiac.2013.11.003. Epub 2013 Dec 11.
6
Active immunization against tetanus in man. II. Combined active and passive prophylaxis with human tetanus immune globulin.人体破伤风主动免疫。II. 人破伤风免疫球蛋白联合主动与被动预防
Z Immunitatsforsch Exp Klin Immunol. 1976 Apr;151(3):191-201.
7
[Local reactions after repeated tetanus vaccinations].
Schweiz Med Wochenschr. 1979 Oct 6;109(38):1409-10.
8
Tetanus and diphtheria antitoxin levels following a hospital-based adult immunization program.基于医院的成人免疫规划后的破伤风和白喉抗毒素水平
Am J Epidemiol. 1975 May;101(5):438-43. doi: 10.1093/oxfordjournals.aje.a112111.
9
Booster effect of low doses of tetanus toxoid in elderly vaccinees.
Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):195-9. doi: 10.1007/s100960050458.
10
Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds.急诊科伤口就诊患者的破伤风免疫情况及医生对破伤风预防措施的依从性
Ann Emerg Med. 2004 Mar;43(3):305-14. doi: 10.1016/j.annemergmed.2003.09.017.

引用本文的文献

1
Evaluation of the safety and pharmacokinetic profile of a new, pasteurized, human tetanus immunoglobulin administered as sham, postexposure prophylaxis of tetanus.对一种新型巴氏杀菌人破伤风免疫球蛋白进行安全性和药代动力学评估,该产品用于破伤风暴露后预防,采用假处理方式给药。
Antimicrob Agents Chemother. 1998 Feb;42(2):298-305. doi: 10.1128/AAC.42.2.298.